Brii Biosciences Limited
BRIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,348 | $669 | $665 | $1,189 |
| - Cash | $1,508 | $1,003 | $656 | $490 |
| + Debt | $7 | $28 | $20 | $3 |
| Enterprise Value | -$153 | -$306 | $29 | $703 |
| Revenue | $0 | $14 | $22 | $16 |
| % Growth | -96.4% | -37.3% | 36.5% | – |
| Gross Profit | $0 | $14 | $22 | $16 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$87 | -$94 | -$213 | -$275 |
| % Margin | -17,435% | -673.6% | -962.7% | -1,696.2% |
| Net Income | -$74 | -$114 | -$281 | $15 |
| % Margin | -14,911.1% | -819.4% | -1,266.2% | 93% |
| EPS Diluted | -0.1 | -0.16 | -0.38 | 0.021 |
| % Growth | 37.5% | 57.9% | -1,926.9% | – |
| Operating Cash Flow | $0 | -$147 | -$226 | -$240 |
| Capital Expenditures | $0 | -$2 | -$1 | $0 |
| Free Cash Flow | $0 | -$150 | -$227 | -$240 |